New Jersey-based manufacturer Sanofi has reached an agreement to settle 4,000 lawsuits linking the active ingredient in Zantac - rantidine - to cancers. Zantac, an over-the-counter pill for ...

Sanofi discontinued the ranitidine formulation of Zantac, and the new formulation, Zantac 360, is made with a different active ingredient. The Good Doctor kills off main character in final season ...

Sanofi has agreed to settle approximately 4,000 personal injury claims from users of its heartburn drug Zantac, resolving litigation in all U.S. state courts besides Delaware, the company ...

opens new tab has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday. Sanofi did not disclose ...

French pharmaceutical giant Sanofi said Thursday it had reached a preliminary agreement on settling thousands of US lawsuits concerning its heartburn drug Zantac. A spokesman said that all bodily ...

Sanofi said it reached an agreement in principle to settle about 4,000 claims around allegations that its heartburn drug Zantac caused cancer. The company said in a statement on Wednesday that the ...

Sanofi has maintained there is no evidence Zantac exposed users to harmful levels of NDMA. The drugmaker now sells the reformulated heartburn medicine Zantac360.

Sanofi shares rose as much as 1.1% in Paris trading. GSK was little changed in London. Concerns about Sanofi’s and other drugmakers’ exposure to Zantac suits helped wipe out about $45 billion ...